Tirosint and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tirosint (levothyroxine sodium) and Ipratropium bromide (ipratropium bromide). Common drug interactions include sinusitis among females.

The phase IV clinical study analyzes what interactions people have when they take Tirosint and Ipratropium bromide. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Tirosint?

Tirosint has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 5,000 Tirosint users. Check the latest studies of Tirosint.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.



On Jul, 05, 2026

15 people who take Tirosint and Ipratropium bromide together, and have interactions are studied.

Tirosint and Ipratropium bromide drug interactions.

What are the common drug interactions of Tirosint and Ipratropium Bromide, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Body temperature increased
  3. Body temperature decreased
  4. Cough
  5. Diarrhoea
  6. Drug hypersensitivity
  7. Dyspnoea (difficult or laboured respiration)
  8. Eye pruritus (eye itching)
  9. Eye swelling
  10. Fatigue (feeling of tiredness)

male:

n/a

What are the common drug interactions of Tirosint and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cystitis escherichia (inflammation of the wall of the bladder by bacteria escherichia coli)
  2. Lymph gland infection
  3. Mastitis (inflammation of breast)

50-59:

  1. Body temperature increased
  2. Chills (felling of cold)
  3. Influenza
  4. Respiratory tract infection
  5. Sinusitis (inflammation of sinus)
  6. Streptococcal infection
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Upper respiratory tract infection
  9. Diarrhoea
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Body temperature decreased
  2. Cough
  3. Acute sinusitis
  4. Death
  5. Drug hypersensitivity
  6. Eye pruritus (eye itching)
  7. Eye swelling
  8. Insomnia (sleeplessness)
  9. Keloid scar (overgrown scars left from skin injuries)
  10. Ocular hyperaemia (an abnormally large amount of blood in eye)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 40.00%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 20.00%
  3. Asthma: 2 people, 13.33%
  4. Sinusitis (inflammation of sinus): 1 person, 6.67%
  5. Seasonal Allergy (allergic condition due to certain season): 1 person, 6.67%
  6. Paranasal Sinus Discomfort: 1 person, 6.67%
  7. Oropharyngeal Pain: 1 person, 6.67%
  8. Immunodeficiency: 1 person, 6.67%
  9. Hyperglycemia (high blood sugar): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tirosint and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tirosint and Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tirosint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tirosint and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and ipratropium bromide (the active ingredients of Tirosint and Ipratropium bromide, respectively), and Tirosint and Ipratropium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: